Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Boland BB"'
Autor:
Christiaens A; FNRS, Fund for Scientific Research, Bruxelles, Belgium antoine.christiaens@uclouvain.be.; Clinical Pharmacy research group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.; Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, Île-de-France, France., Simon-Tillaux N; Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, Île-de-France, France.; Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité́ de Recherche Clinique PSL-CFX, CIC-1901, Assistance Publique - Hôpitaux de Paris, Paris, Île-de-France, France., Thompson W; Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; Research Unit of General Practice, University of Southern Denmark, Odense, Denmark., Sinclair AJ; Care for long term conditions - Diabetes research group, King's College London, London, UK.; Foundation for Diabetes Research in Older People, Taplow, UK., Henrard S; Clinical Pharmacy research group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.; Institute of Health and Society, Université catholique de Louvain, Brussels, Belgium., Boland BB; Institute of Health and Society, Université catholique de Louvain, Brussels, Belgium.; Geriatric Department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium., Slaouti-Jégou Y; Claude Bernard, Resip, Boulogne-sur-mer, France., Lekens B; Claude Bernard, Resip, Boulogne-sur-mer, France., Bonnet-Zamponi D; Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, Île-de-France, France.; Observatoire des médicaments, dispositifs médicaux, innovations thérapeutiques d'Île-de-France, Paris, France., Tubach F; Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, Île-de-France, France.; Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité́ de Recherche Clinique PSL-CFX, CIC-1901, Assistance Publique - Hôpitaux de Paris, Paris, Île-de-France, France., Zerah L; Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, Île-de-France, France.; Hôpital Pitié Salpêtrière, Département de gériatrie, Assistance Publique - Hôpitaux de Paris, Paris, Île-de-France, France.
Publikováno v:
BMJ open [BMJ Open] 2023 Nov 19; Vol. 13 (11), pp. e073081. Date of Electronic Publication: 2023 Nov 19.
Autor:
Boland BB; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gubra ApS, Horsholm, Denmark; PRECISIONscientia, Yardley, PA, USA., Laker RC; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., O'Brien S; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sitaula S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sermadiras I; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Nielsen JC; Gubra ApS, Horsholm, Denmark., Barkholt P; Gubra ApS, Horsholm, Denmark., Roostalu U; Gubra ApS, Horsholm, Denmark., Hecksher-Sørensen J; Gubra ApS, Horsholm, Denmark., Sejthen SR; Gubra ApS, Horsholm, Denmark., Thorbek DD; Gubra ApS, Horsholm, Denmark., Suckow A; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; DTX Pharma, San Diego, CA, USA., Burmeister N; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Roche, Penzberg, Germany., Oldham S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Will S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Howard VG; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gill BM; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Newton P; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Naylor J; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hornigold DC; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Austin J; University of Chicago Advanced Electron Microscopy Core Facility, Chicago, IL, USA., Lantier L; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA., McGuinness OP; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA., Trevaskis JL; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gilead Sciences, Foster City, CA, USA., Grimsby JS; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Rhodes CJ; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: christopher.rhodes@astrazeneca.com.
Publikováno v:
Molecular metabolism [Mol Metab] 2022 Jan; Vol. 55, pp. 101392. Date of Electronic Publication: 2021 Nov 12.
Autor:
Kang T; Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark; The Danish Diabetes Academy, Odense, Denmark., Boland BB; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism, University of Chicago, Chicago, Illinois 60637; Cardiovascular, Renal and Metabolic Disease, BioPharmaceuticals Research and Development, AstraZeneca Gaithersburg, Maryland 20878., Jensen P; Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark., Alarcon C; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism, University of Chicago, Chicago, Illinois 60637., Nawrocki A; Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark., Grimsby JS; Cardiovascular, Renal and Metabolic Disease, BioPharmaceuticals Research and Development, AstraZeneca Gaithersburg, Maryland 20878., Rhodes CJ; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism, University of Chicago, Chicago, Illinois 60637; Cardiovascular, Renal and Metabolic Disease, BioPharmaceuticals Research and Development, AstraZeneca Gaithersburg, Maryland 20878., Larsen MR; Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark. Electronic address: mrl@bmb.sdu.dk.
Publikováno v:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2020 Jun; Vol. 19 (6), pp. 971-993. Date of Electronic Publication: 2020 Apr 07.
Autor:
Boland ML; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Laker RC; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Mather K; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Nawrocki A; Department of Biochemistry and Molecular Biology, PR group, University of Southern Denmark, Odense, Denmark., Oldham S; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Boland BB; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Lewis H; Research and Early Development, Oncology, AstraZeneca, Cambridge, UK., Conway J; Translational Sciences, AstraZeneca, Gaithersburg, MD, USA., Naylor J; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Guionaud S; Global Pathology, AstraZeneca, Cambridge, UK., Feigh M; Gubra, Hørsholm, Denmark., Veidal SS; Gubra, Hørsholm, Denmark., Lantier L; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA., McGuinness OP; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA., Grimsby J; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Rondinone CM; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Jermutus L; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Larsen MR; Department of Biochemistry and Molecular Biology, PR group, University of Southern Denmark, Odense, Denmark., Trevaskis JL; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Gilead Sciences, Foster City, CA, USA., Rhodes CJ; Research and Early Development, Cardiovascular, Renal and Metabolic Diseases, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Christopher.Rhodes@astrazeneca.com.
Publikováno v:
Nature metabolism [Nat Metab] 2020 May; Vol. 2 (5), pp. 413-431. Date of Electronic Publication: 2020 May 21.
Autor:
Sembach FE; Gubra ApS, Hørsholm, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Fink LN; Gubra ApS, Hørsholm, Denmark., Johansen T; Gubra ApS, Hørsholm, Denmark., Boland BB; Gubra ApS, Hørsholm, Denmark., Secher T; Gubra ApS, Hørsholm, Denmark., Thrane ST; Gubra ApS, Hørsholm, Denmark., Nielsen JC; Gubra ApS, Hørsholm, Denmark., Fosgerau K; Gubra ApS, Hørsholm, Denmark., Vrang N; Gubra ApS, Hørsholm, Denmark., Jelsing J; Gubra ApS, Hørsholm, Denmark., Pedersen TX; Gubra ApS, Hørsholm, Denmark., Østergaard MV; Gubra ApS, Hørsholm, Denmark.
Publikováno v:
Physiological reports [Physiol Rep] 2019 Dec; Vol. 7 (24), pp. e14333.
Autor:
Kang T; Protein Research Group, Department of Biochemistry and Molecular Biology , University of Southern Denmark , DK-5230 Odense M , Denmark.; The Danish Diabetes Academy , 5000 Odense , Denmark., Boland BB; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism , University of Chicago , Chicago , Illinois 60637 , United States.; Cardiovascular, Renal and Metabolic Disease Research , MedImmune LLC , Gaithersburg , Maryland 20878 , United States., Alarcon C; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism , University of Chicago , Chicago , Illinois 60637 , United States., Grimsby JS; Cardiovascular, Renal and Metabolic Disease Research , MedImmune LLC , Gaithersburg , Maryland 20878 , United States., Rhodes CJ; The Kovler Diabetes Center, Department of Medicine Section of Endocrinology, Diabetes & Metabolism , University of Chicago , Chicago , Illinois 60637 , United States.; Cardiovascular, Renal and Metabolic Disease Research , MedImmune LLC , Gaithersburg , Maryland 20878 , United States., Larsen MR; Protein Research Group, Department of Biochemistry and Molecular Biology , University of Southern Denmark , DK-5230 Odense M , Denmark.
Publikováno v:
Journal of proteome research [J Proteome Res] 2019 Sep 06; Vol. 18 (9), pp. 3245-3258. Date of Electronic Publication: 2019 Jul 31.
Autor:
Boland BB; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Mumphrey MB; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Hao Z; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Townsend RL; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Gill B; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Oldham S; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Will S; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Morrison CD; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Yu S; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Münzberg H; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Rhodes CJ; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Trevaskis JL; Cardiovascular, Renal and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD, USA., Berthoud HR; Pennington Biomedical Research Center, Baton Rouge, LA, USA. Electronic address: berthohr@pbrc.edu.
Publikováno v:
Molecular metabolism [Mol Metab] 2019 Jul; Vol. 25, pp. 64-72. Date of Electronic Publication: 2019 May 09.
Autor:
Boland BB; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD bbo@gubra.dk.; Gubra ApS, Hørsholm, Denmark., Brown C Jr; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Boland ML; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD.; Gubra ApS, Hørsholm, Denmark., Cann J; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Sulikowski M; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Hansen G; Gubra ApS, Hørsholm, Denmark., Grønlund RV; Gubra ApS, Hørsholm, Denmark., King W; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Rondinone C; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Trevaskis J; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Rhodes CJ; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD., Grimsby JS; Division of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD.
Publikováno v:
Diabetes [Diabetes] 2019 Jan; Vol. 68 (1), pp. 131-140. Date of Electronic Publication: 2018 Oct 10.
Autor:
Boland ML; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States., Oldham S; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States., Boland BB; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States., Will S; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States., Lapointe JM; Pathology, MedImmune Ltd., Cambridge CB21 6GH, United Kingdom., Guionaud S; Pathology, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge CB22 3AT, United Kingdom., Rhodes CJ; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States., Trevaskis JL; Cardiovascular and Metabolic Diseases, MedImmune LLC, Gaithersburg, MD 20878, United States. trevaskisj@medimmune.com.
Publikováno v:
World journal of gastroenterology [World J Gastroenterol] 2018 Apr 28; Vol. 24 (16), pp. 1748-1765.
Autor:
Cohen TS; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA. Electronic address: cohent@medimmune.com., Boland ML; Department of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD, USA., Boland BB; Department of Cardiovascular and Metabolic Disease, MedImmune LLC, Gaithersburg, MD, USA., Takahashi V; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA., Tovchigrechko A; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA., Lee Y; Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA., Wilde AD; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Mazaitis MJ; Nascent Studio, Ann Harbor, MI, USA., Jones-Nelson O; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA., Tkaczyk C; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA., Raja R; Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA., Stover CK; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA., Sellman BR; Department of Infectious Disease, MedImmune LLC, Gaithersburg, MD, USA.
Publikováno v:
Cell reports [Cell Rep] 2018 Feb 27; Vol. 22 (9), pp. 2431-2441.